T. Rowe Price Investment Management
XRAY icon

T. Rowe Price Investment Management’s Dentsply Sirona XRAY Stock Holding History

T. Rowe Price Investment Management’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-205
Closed -$3K – 958
2025
Q3 		$3K Buy
+205
New +$2.98K ﹤0.01% 840
2025
Q1 		– Sell
-792,515
Closed -$15M – 704
2024
Q4 		$15M Sell
792,515
-372,322
-32% -$7.87M 0.01% 538
2024
Q3 		$31.5M Sell
1,164,837
-8,234,446
-88% -$210M 0.02% 471
2024
Q2 		$234M Buy
9,399,283
+732,178
+8% +$21M 0.15% 161
2024
Q1 		$288M Buy
8,667,105
+1,190,252
+16% +$40.7M 0.18% 146
2023
Q4 		$266M Buy
7,476,853
+2,457,416
+49% +$78M 0.17% 149
2023
Q3 		$171M Sell
5,019,437
-31,100
-0.6% -$1.18M 0.12% 193
2023
Q2 		$202M Sell
5,050,537
-25,241
-0.5% -$1M 0.14% 169
2023
Q1 		$199M Sell
5,075,778
-7,556
-0.1% -$277K 0.14% 160
2022
Q4 		$162M Buy
5,083,334
+1,030,275
+25% +$31.1M 0.12% 181
2022
Q3 		$115M Buy
+4,053,059
New +$139M 0.09% 222

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

T. Rowe Price Investment Management's XRAY Position: Q4 2025 in Review

T. Rowe Price Investment Management sold out of Dentsply Sirona (XRAY) in Q4 2025, closing a stake of 205 shares — an estimated $3K sold.

T. Rowe Price Investment Management first reported a position in XRAY in Q3 2022 and held it in 11 quarters. The position peaked at $288M in Q1 2024. 361 funds tracked by Wall St. Rank hold XRAY as of Q4 2025.

  • T. Rowe Price Investment Management reported no remaining Dentsply Sirona position as of Q4 2025 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 205 Dentsply Sirona shares in Q4 2025, an estimated $3K.
  • T. Rowe Price Investment Management first reported a position in Dentsply Sirona in Q3 2022 and held it in 11 quarters.
  • T. Rowe Price Investment Management's Dentsply Sirona position peaked at $288M in Q1 2024.
  • 361 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2025.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.